Search by Drug Name or NDC

    NDC 00378-0403-05 Spironolactone and Hydrochlorothiazide 25; 25 mg/1; mg/1 Details

    Spironolactone and Hydrochlorothiazide 25; 25 mg/1; mg/1

    Spironolactone and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is HYDROCHLOROTHIAZIDE; SPIRONOLACTONE.

    Product Information

    NDC 00378-0403
    Product ID 0378-0403_a7e73fee-cca8-4726-b50b-1c2dfc5e870f
    Associated GPIs 37990002200310
    GCN Sequence Number 006813
    GCN Sequence Number Description spironolact/hydrochlorothiazid TABLET 25 MG-25MG ORAL
    HIC3 R1L
    HIC3 Description POTASSIUM SPARING DIURETICS IN COMBINATION
    GCN 82330
    HICL Sequence Number 002900
    HICL Sequence Number Description SPIRONOLACTONE/HYDROCHLOROTHIAZIDE
    Brand/Generic Generic
    Proprietary Name Spironolactone and Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name spironolactone and hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 25; 25
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
    Labeler Name Mylan Pharmaceuticals Inc.
    Pharmaceutical Class Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA086513
    Listing Certified Through 2024-12-31

    Package

    NDC 00378-0403-05 (00378040305)

    NDC Package Code 0378-0403-05
    Billing NDC 00378040305
    Package 500 TABLET in 1 BOTTLE, PLASTIC (0378-0403-05)
    Marketing Start Date 1979-08-03
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.64541
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis